The House of Lords Science and Technology Committee has announced that it will hear from three further witnesses in its regenerative medicine inquiry.
They are Alastair Kent, director of patient charity Genetic Alliance UK; Chris Bravery, principal consultant at regulatory consultancy Consulting on Advanced Biologicals; and an unconfirmed witness from LGC, the chemical and DNA analysis company.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.